Correlation Between Passage Bio and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Passage Bio and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and C4 Therapeutics, you can compare the effects of market volatilities on Passage Bio and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and C4 Therapeutics.
Diversification Opportunities for Passage Bio and C4 Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Passage and CCCC is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Passage Bio and C4 Therapeutics
Given the investment horizon of 90 days Passage Bio is expected to under-perform the C4 Therapeutics. In addition to that, Passage Bio is 1.17 times more volatile than C4 Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. C4 Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest 133.00 in C4 Therapeutics on May 31, 2025 and sell it today you would earn a total of 122.00 from holding C4 Therapeutics or generate 91.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Passage Bio vs. C4 Therapeutics
Performance |
| Timeline |
| Passage Bio |
| C4 Therapeutics |
Passage Bio and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Passage Bio and C4 Therapeutics
The main advantage of trading using opposite Passage Bio and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Passage Bio vs. Q32 Bio | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Black Diamond Therapeutics |
| C4 Therapeutics vs. Foghorn Therapeutics | C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |